MedPath

To see the effect of Chakshushya Basti followed by Triphaladi Ghrita Aschyotana and Triphalayasadi Yoga orally in Timira (Simple Myopia).

Phase 2
Not yet recruiting
Conditions
Myopia. Ayurveda Condition: TIMIRAH,
Registration Number
CTRI/2023/08/056608
Lead Sponsor
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan
Brief Summary

This study is a Clinical Evaluation of Chakshushya Basti followed by Triphaladi Ghrita Aschyotana and Triphalayasadi Yoga orally in timira (Simple myopia)â€. This will be conducted on 60 patients from OPD/IPD of Shalakya - Tantra Department of Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar. Patients will be divided into two groups - 30 patients will be given Chakshushya Basti followed by Triphaladi Ghrita Aschyotana and Triphalayasadi Yoga orally and 30 patients will be given Placebo topically and orally. 1st follow up after 15 days of basti treatment and 2nd follow up at the completion of treatment. Assessment will be done on the basis of subjective and objective parameters as discussed earlier.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients with classical symptoms of Timira and simple myopia (up to -6D).
  • Patients between the age group of 8 years to 30 years of either sex.
Exclusion Criteria
  • Patients having age less than 8 years and more than 30 years.
  • Patients having high myopia (>6D).
  • Patients suffering from any other eye diseases like corneal xerosis, corneal ulcer, corneal opacity, cataract, diabetic retinopathy, macular degeneration etc.
  • retinal diseases.
  • Patients suffering from other systemic diseases & metabolic disorders.
  • Patients with classical contra-indicatory conditions for Basti.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
assessment will be made on the basis of subjective & objective criteria.0, 3 weeks, 8 weeks
blood investigation - CBC to exclude any systemic disease, HbA1C to exclude diabetes.0, 3 weeks, 8 weeks
Secondary Outcome Measures
NameTimeMethod
assessment will be made on the basis of subjective & objective criteria.blood investigation - CBC to exclude any systemic disease, HbA1C to exclude diabetes.

Trial Locations

Locations (1)

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan

🇮🇳

Hardwar, UTTARANCHAL, India

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan
🇮🇳Hardwar, UTTARANCHAL, India
Jasmeen Saini
Principal investigator
9872755662
jspabla20@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.